All HHS Contracts — October 29, 2026

The National Opinion Research Center's cost-plus-fixed-fee NCI contract carries a base-plus-options value of $29,760,269 against $21,432,411 obligated, leaving roughly $8.3 million subject to future option exercises through a potential 2028-06-03 end date.

The $21,432,411 award flows to a Chicago-based nonprofit classified as tax-exempt and not a small business, so the investment relevance is limited to sector signals and any undisclosed partner or subcontractor exposure rather than a tradable issuer.

A 2018-start full-and-open-competition award (NAICS 541990, PSC R408) with a current end of 2027-06-03 and potential end of 2028-06-03 signals sustained federal health-research spending on cohort studies, supporting the professional/scientific services sector broadly.

The NORC/NCI cohort study depends on NIH/NCI appropriations; the data does not reveal year-over-year budget direction, and the roughly $8.3 million gap between obligation and ceiling is contingent on future funding and option exercises.

The contract is cost-plus-fixed-fee, which shifts cost-overrun risk to the government but still exposes performance and re-compete risk at the 2027-06-03 current end date; pricing risk is assessed as medium.

The award was made under full and open competition with no set-aside, so the incumbent relationship is not protected by small-business or 8(a) preferences and could be contested at re-compete.

Option exercises on the NORC/NCI contract could add up to roughly $8.3 million in obligations toward the $29,760,269 ceiling, extending work through a potential 2028-06-03 end date.

Sustained NIH/NCI funding for a multi-year prospective U.S. cancer cohort study signals continued civilian health-research demand for professional program management and research support services (NAICS 541990, PSC R408).

A 2018-start, full-and-open-competition NCI cohort study contract with a $29,760,269 ceiling and a potential 2028 end date illustrates multi-year civilian research funding, though the data does not reveal year-over-year budget direction.

The NORC award is cost-plus-fixed-fee under NAICS 541990 and PSC R408, indicating program management and research support services rather than a discrete technology build-out.

{"entity" => "National Opinion Research Center (NORC)", "reason" => "Holds a $21,432,411 obligated / $29,760,269 ceiling NCI cost-plus contract with roughly $8.3 million unexercised and $13,191,881 outlayed to date.", "trigger" => "Option exercise decisions between the 2027-06-03 current end date and 2028-06-03 potential end date"}

{"entity" => "NIH National Cancer Institute", "reason" => "Awarding agency for the $21,432,411 cohort study; future obligations depend on NCI appropriations and study priorities.", "trigger" => "NIH/NCI budget appropriations and any change to cancer cohort study priorities"}

{"entity" => "Civilian government-services / research-support sector", "reason" => "The sole award is 100% civilian (0/1 defense-related), offering a sector signal for NIH-facing services providers rather than a direct equity catalyst.", "trigger" => "Next NIH/NCI award flow or re-compete announcement near 2027-06-03"}